News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

NextFerm Technologies Obtains US Regulatory Marketing Approval for Astaferm® Astaxanthin Antioxidant, in Oil for Soft-Gels

NextFerm Technologies Ltd.

NextFerm Technologies (TASE:NXFR), a food-tech company developing ProteVin™, a vegan, yeast-based, non-GMO protein alternative and other innovative yeast-based nutrients, today announced receipt of regulatory marketing approval (Self-GRAS) for Astaferm®, its innovative fermented astaxanthin antioxidant in the form of Oil for Soft-Gels, in the US. Astaferm® is already sold in the US and Canada in the form of Gummies and powder by well-established Brands in North America. NextFerm expects initial Purchase orders for the oil during 2021. NextFerm currently prepares to expand the marketing of Astaferm® for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages. Boaz Noy, Chief Executive Officer of NextFerm, said, “ Soft-Gels is the most popular form of consumption of Astaxanthin. This marketing approval allows NextFerm to expand its value proposition in the market, while increasing market awareness and offer fermented Astaxanthin in the form of oil with a competitive price, in addition to Astaxanthin in Gummies. we believe it will contribute to revenues growth in the coming quarters.” About NextFerm Technologies NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE:NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives. NextFerm's flagship product is ProteVin™, a vegan, yeast-derived protein alternative with nutritional value that is similar to animal-derived protein and a neutral flavor, with no aftertastes that are typical of plant-based protein. ProteVin™ is designed for a variety of categories in the alternative protein market, which is estimated at $13 billion, with an annual growth rate of 10%, including milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. NextFerm is gearing up for commercialization of the product in the US in 2022. Another product currently being sold is Astaferm®, an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. In July 2021, the Company received Regulatory Marketing Approval for Astaferm® in Canada. The company has additional products which have been licensed to Lallemand, a global giant focused on yeast. For more information, visit the NextFerm website at: www.nextferm.com Legal Notice Regarding Forward-Looking Statements This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company’s control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company’s operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company’s current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company’s operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details Nextferm Technologies Ltd. Yossi Ohana - Chief Financial Officer +972 54-771-5893 yossio@nextferm.com Investor and Media contact Meirav Gomeh-Bauer +972 54-476-4979 meirav@bauerg.com Company Website https://www.nextferm.com/

September 02, 2021 02:29 PM Eastern Daylight Time

Article thumbnail News Release

The Meningitis Vaccines: What Parents of Adolescents Should Know

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/OpbXUBrzUA4 According to the CDC, COVID-19 disrupted routine well-child visits for many children over the last year. As a result, too many children have fallen behind on receiving recommended vaccines – and that includes adolescents and young adults. If young adults are not receiving these recommended vaccinations, they are now vulnerable to infectious, potentially deadly diseases. So are the campuses and communities they live in. One vaccine that often gets left behind is Meningitis B, which is recommended for adolescents 16-23 years old. There are two types of meningitis vaccines – MenACWY and MenB. Few have received the MenB vaccine, yet it’s responsible for 100% of meningococcal meningitis outbreaks on college campuses since 2011. One issue? A lack of communication from pediatricians and family physicians. A recent study found that 49% of pediatricians and 69% of family physicians did not discuss the MenB vaccine during routine visits for 16-18-year-olds. That’s one reason why research shows that nearly 80% of parents did not know about the MenB vaccine, and why more than 78.2% of 17-year-olds have not received at least one dose of the Meningitis B vaccine. As kids head back to school, it’s important that parents take the time to check what vaccinations their teens and young adults have received and proactively talk to their healthcare provider about what other vaccines they need – including both the MenACWY and MenB meningitis vaccines. For more information visit: https://meningitisbactionproject.org/ About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

September 02, 2021 01:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

YuMOVE Offers Tips for Walking Your New Pandemic Puppy

Lintbells

For many across the country, new work from home policies, quarantines, social distancing, and loneliness all added to the appeal of adding a new puppy to the home. Whether the timing was right for a pandemic puppy or owners had been planning on a new puppy for a while, there’s no doubt pet ownership is on the rise. Bringing a puppy home for the first time can be exciting, with owners anxious to get out for ‘walkies’ as soon as possible. But too much exercise especially high-impact exercise, can be bad for puppies and increase the chance of broken bones. “When a puppy is born, its bones are not fully formed,” said Veterinarian Dr. Craig Prior, B.V.Sc., C.V.J., member of YuMOVE veterinary advisory board. “The age at which the growth plates close or stop growing varies hugely between individuals, breeds and joints, but tends to be somewhere between six months and two-and-a-half years, with an average of about a year. Some studies have suggested that too much exercise before these growth plates close can put strain on joints and increase the risk of various bone and joint conditions.” Here’s a helpful chart to reference before taking your puppy out. Other tips to keep in mind when walking puppies include: Walk don’t run – Until your puppy is fully grown, avoid taking them for a jog, cycle ride, or any other type of vigorous exercise. Pay attention- While you’re walking, pay attention to your puppy, and stop if you notice them getting tired – even if it’s been less than the recommended exercise time. Vaccinations- avoid other dogs and public areas until 5-7 days after vaccination round two to keep them from getting sick. Heat- puppies, like adult dogs and humans, can be at risk for heatstroke if temperatures get too hot. Keep puppies inside if the temperature exceeds 90 degrees and pay attention to the pavement temperature as the ground can get much hotter than the surrounding air. Hold the back of your hand to the pavement for 10 seconds. If you can’t hold for the full amount, it’s too hot for your puppy as well. Play- Gentle tug of war games and rolling a ball slowly for your pup is okay, but Charging after a ball that has been thrown, or excessive rough and tumble with a larger dog should be avoided. Pet owners should talk with their veterinarian about any questions or concerns with their puppy’s activity or growing hips/joints. Being proactive and taking steps to optimize the health of your younger dog once they get to be about three years of age is a good thing as well! It means they’ll be less likely to develop problems with stiffness and mobility as they grow older. Supplements can be used by younger dogs- not recommended for use on puppies- but be sure to look for a product designed especially to support active and growing joints such as YuMOVE Young & Active joint support for dogs 5 years and younger. Interviews, additional veterinarian advice and supporting documentation available upon request. For more information on hip/joint health and keeping pets active for life, please visit https://yumove.com/blogs/health-guides. About YuMOVE YuMOVE is clinically proven* and the #1 hip and joint supplement in the UK** now available in the US. YuMOVE is on a mission to keep pets ‘active for life’ which is why we are committed to making the best joint support products in the world. Packed with unique ActivEase® Green Lipped Mussels, sustainably sourced from select New Zealand bays, YuMOVE is full of antioxidants and Omega 3. Its unique premium formula aids joint development supports active joints and structure and promotes mobility. www.yumove.com *Study conducted by the Royal Veterinary College of London, United Kingdom **Kynetec VetTrak data, sales through veterinary wholesalers, February 2021 About Lintbells Lintbells, the UK's #1 Vet Recommended Dog Joint Supplement company, currently helps more than 1 million dogs across Europe and the United States. In March 2019, Lintbells officially entered the US Market with the introduction of their most popular product abroad, YuMOVE Soft Chews. This joint supplement promotes joint and cartilage health in dogs of all breeds and sizes. Made from all-natural, human-grade, non-GMO ingredients, the secret to YuMOVE Soft Chews' success comes from Lintbells own ActivEase® Green Lipped Mussel (or GLM). GLM, a superfood derived from the purest sources in New Zealand, is an essential ingredient with extraordinary properties that improves joint function, mobility, and reduces discomfort in our dogs. This unique ingredient, rich with more Omega 3s than any other GLM, is naturally anti-inflammatory, meaning our dog's stiff joints are eased naturally. To learn more, visit www.yumove.com Contact Details Jamie Baxter +1 775-322-4022 jamie@theimpetusagency.com Company Website https://yumove.com/

August 31, 2021 10:31 AM Pacific Daylight Time

Article thumbnail News Release

American Kidney Fund Activates Disaster Relief Program to Support Dialysis and Post-Transplant Patients Affected by Hurricane Ida

American Kidney Fund

The American Kidney Fund (AKF), the leading nonprofit working on behalf of 37 million Americans living with kidney disease, has activated its Disaster Relief Program to provide $200 emergency grants to dialysis and post-transplant patients in Louisiana who have been affected by Hurricane Ida, which made landfall on Sunday as a category 4 hurricane. AKF’s Disaster Relief Program is the nation’s only rapid-response system that provides emergency financial assistance to dialysis and recent transplant patients. When disaster strikes their communities, AKF disaster relief grants help kidney patients replace lost medications and special renal diet foods, pay for temporary housing and transportation to treatment, and replace clothing and personal essentials lost due to the natural disaster or the need to evacuate with short notice. Louisiana dialysis and recent kidney transplant patients who need emergency financial help should contact a social worker at their dialysis clinic for information on applying for aid or submit an application directly at gms.KidneyFund.org. “Natural disasters, such as Hurricane Ida, create further challenges for dialysis and post-transplant patients on top of keeping themselves and their families safe, such as making arrangements to continue receiving their life-sustaining treatments,” said LaVarne A. Burton, AKF President and CEO. “With individual resources already spread thin 18 months into the COVID-19 pandemic, the impact of these natural disasters could be devastating for many. Our Disaster Relief Program helps to relieve some of the financial burdens patients face in the wake of disaster.” AKF’s website provides emergency resources for patients effected by Hurricane Ida. AKF additionally has general emergency preparedness information for dialysis and post-transplant patients at KidneyFund.org/disaster-prep. This page includes information about the 3-Day Emergency Diet Plan for dialysis patients. By following this plan, kidney patients can help reduce waste buildup in their bodies if they have to miss or delay their dialysis treatments. AKF has been providing emergency disaster financial assistance to kidney patients throughout all the major disasters that have struck the United States and its territories for the past two decades. In 2020, AKF provided $62,000 in disaster relief grants to 333 patients affected by Hurricanes Laura and Sally and the Oregon wildfires. AKF also activated its Coronavirus Emergency Fund in March 2020 and has provided over $3.1 million in assistance to nearly 13,000 low-income dialysis and transplant patients during the pandemic. To make a contribution to AKF’s Disaster Relief Program to assist kidney patients affected by Hurricane Ida, visit AKF’s online donation page. 100% of all donations go directly to patients affected by Hurricane Ida. AKF is covering the cost of grant processing and check distribution to ensure that the maximum number of patients in need receive the support they so desperately need. About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. Contact Details Stefanie Tuck +1 202-470-1797 11921 Rockville Pike, Suite 300, Rockville, MD 20852 AKF@jpa.com Company Website https://www.kidneyfund.org

August 30, 2021 01:31 PM Eastern Daylight Time

Article thumbnail News Release

Elsevier appoints health analytics industry leader Josh Schoeller as President, Clinical Solutions

Elsevier

Elsevier, a global leader in research publishing and information analytics, announced today that Josh Schoeller has been appointed President of its Clinical Solutions business unit, which serves healthcare professionals around the world by providing evidence-based content, health analytics and digital solutions to help improve patient outcomes. Mr. Schoeller has more than 30 years of experience leading and scaling businesses focused on Big Data, predictive analytics, application architecture, and decision support to advance patient care and quality improvements across healthcare. Since 2018 Mr. Schoeller has served as CEO of the healthcare business of Lexis Nexis Risk Solutions, part of RELX. He will maintain his CEO responsibilities for Healthcare at LexisNexis Risk Solutions in addition to his leadership role with Clinical Solutions. Jan Herzhoff, President, Health at Elsevier said: “Josh has a strong track record of success working across multiple segments in healthcare and building high-performing organizations. We are thrilled to have Josh’s leadership and look forward to exploring additional synergies between the healthcare business of LexisNexis Risk Solutions and Clinical Solutions, especially in the field of advanced provider analytics, which is a key area of focus for Elsevier.” Mr. Schoeller joined LexisNexis Risk Solutions in 2013 through the acquisition of Enclarity. While at Enclarity, he served as the Vice President, Chief Solution Architect responsible for delivering industry-leading provider data management solutions for healthcare providers. Prior to this role, he spent 15 years at FICO, a data analytics company, where he held diverse roles in information technology, sales and operations. Mr. Schoeller currently serves on the Board of the eHealth Initiative and Foundation (eHI) and is a member of the Forbes Business Development Council. Mr. Schoeller added: “At the heart of improving healthcare is effectively applying outcomes-driven analytics across the care continuum. I’m excited about the tremendous opportunity to combine the market-leading evidence-based content and clinical reference and workflow solutions of Elsevier Health with our differentiated data and analytics capabilities to support healthcare providers in delivering better outcomes for patients.” Elsevier’s Clinical Solutions business brings evidenced-based content into the care process, empowering healthcare professionals, as well as patients, to make better decisions. Serving over 2,000 healthcare organizations, Elsevier's clinical and technology experts are at the forefront of helping their customers leverage evidence-based content in the EMR and at the point of care. To learn more, visit Elsevier. --- About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details Teresa Mueller, Vice President, Global Health Markets +31 6 20987384 t.mueller@elsevier.com Company Website https://www.elsevier.com/en-xs

August 30, 2021 08:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

GRYT Health Announces New Additions to Board of Directors and Employee Team

GRYT Health

GRYT (“grit”) Health, a digital oncology company that empowers people to be in charge of their own health, announces the appointment of Sheila Thorne, president and chief executive officer, Multicultural Healthcare Marketing Group, LLC, to its Board of Directors. "Sheila Thorne is a powerhouse in the healthcare marketing industry and a champion of patient rights and equality. On behalf of the entire GRYT Health team, I'm sharing our excitement over her addition to our Board of Directors," said Shelley Nolden, cancer survivor, co-founder, and chairwoman of GRYT Health. "We're thrilled to have Sheila join her voice with ours as we work to change healthcare and accelerate GRYT Health's commercial growth and community impact while always preserving our patient-first principles." A native New Yorker and former senior executive in five preeminent marketing and communications companies, Sheila has spent more than two decades designing marketing, media and health education campaigns for the top 50 pharmaceutical companies across a broad range of therapeutic categories from molecule to market. A former high school teacher of foreign languages, she has worked on behalf of the healthcare industry throughout North America, Western Europe and Latin America with a focus on communities of color. She teaches and has lectured on health equity and cultural competency at Quinnipiac University School of Medicine, Rutgers, New York University and Queens College. She has given over 250 keynote presentations and workshops on cultural competency, anti-bias, and diversity. She is published in Pharmaceutical Executive, PharmaVoice, Medical, Marketing & Media and has numerous articles published in a variety of consumer health and ethnic publications. Sheila is known for her unique ability to galvanize communities of color around health and social justice issues. She has been featured in Essence Magazine, Black Enterprise, The Positive Community, Madame Noire, The Network Journal and a frequent panelist during the sessions of the Annual Congressional Black Caucus Health Braintrust, Congressional Hispanic Caucus Health Institute, and the Asian Pacific Islander American Health Forum. Sheila has received numerous awards for her innovative health marketing strategies to reach people of color, including PharmaVOICE Top 100 earlier this month. "I am truly excited to join the GRYT Health Board," stated Sheila Thorne. "I look forward to working with this extraordinary group of patient advocates who use their humanity to reach all those living and surviving with a chronic or life-threatening disease, no matter what they look like, what language they speak, or where they come from." GRYT Health is also proud to announce a significant number of employee additions and promotions. “We are blessed to have seen tremendous business growth this year, which allowed us to significantly invest in increasing our staff, as well as employee growth opportunities, in an ongoing effort to provide direct support to patients and caregivers today, while empowering them to use their experience to improve healthcare tomorrow,” said Dave Craig, cancer survivor, co-founder, and chief executive officer. “A company started and run by cancer survivors, the patient is the center for everything we do. We bring services to others that we wish we would have had during our own diagnoses.” Through its app and desktop platform, GRYT Health offers support services through connection and education, as well as the ability for patients, survivors and caregivers to share their experiences to help others. Currently, working in collaboration with half of the world’s top 10 pharmaceutical companies, GRYT Health champions patient experience research, clinical trial patient activation, and virtual patient education programs, including leading The Advocacy Exchange and The Global Virtual Cancer Conference, now in its third year. GRYT Health is proud to announce the following employee changes: Matt Berner has joined the team as an Umbraco front end developer. He has held similar roles for 15 years and finds joy in creating a digital product that improves people’s lives. Matt is a 2006 graduate of Muhlenberg College and currently lives in Macungie, Pa. Dave Bjork was recently hired as vice president of empowerment. In this role, he leads the business development and project management of virtual patient education programming with our industry partners. He is a lung cancer survivor, advocate, and host of The Research Evangelist podcast, which elevates the voices of others to inform and empower. Dave earned his degree at the University of Pennsylvania and his background includes over 20 years in industry and non-profit management roles. He currently lives in Georgetown, Mass. Christian Bullock was recently promoted to director of digital strategy. In this role, Christian oversees search engine optimization and digital advertising. Having gone through his own cancer diagnosis, Christian found GRYT Health in 2018 and joined the team in an advisory capacity. Christian prides himself on communicating with other cancer patients and survivors in an empathic and understanding way. Prior to joining GRYT Health, Christian cut his teeth in various agency management and digital media roles. He has a particular interest in astronomy and likes to read whenever he can. He graduated from Washington State University and currently resides in Battle Ground, Wash. Rachel Byrd joined the organization in 2020 and was recently promoted to senior research coordinator. She obtained her Bachelors of Science degree in Neuroscience from Central Michigan University and her Masters of Science degree in Health Science with an emphasis in Molecular Medicine from Montana State University. Cancer has touched her life through her younger sister, who is now nearly 20 years cancer free, and through the loss of her aunt and uncle. Rachel grew up in Michigan, but currently calls Bozeman, Mont., home. Megan-Claire Chase was recently hired as partnership director. In this role, she is working to build relationships with non-profit patient advocacy groups to engage their expertise in virtual patient education programs and amplify their resources to support the GRYT Health community. Megan-Claire is an accomplished media and marketing professional with over 15 years of experience in these industries. After being diagnosed with breast cancer (stage IIA invasive lobular) in 2015, she became heavily involved in patient advocacy and research post-treatment. She is a powerful communicator, public speaker, researcher, published writer and blogger of Life on the Cancer Train. In her spare time, she is a consumer reviewer for the Department of Defense Breast Cancer Research Program and a contributing writer for WebMD under their breast cancer section. Megan-Claire and her work has been featured in national press including The New York Times and People Magazine, as well as through numerous patient advocacy organizations. She grew up in Macon, Ga. and received her Bachelors of Arts degree in Communication with a minor in Theatre from The College of Saint Rose in Albany, N.Y. Chris Chamars was recently hired as a programs and partnership specialist. Chris has extensive experience in the healthcare and community relations industries, including time as an EMT, teaching health education and doing community outreach with the Peace Corps in Moldova, and at The Wilson Center in Washington, D.C. He holds a Bachelors of Arts degree in Psychology from St. Michael’s College in Colchester, Vt. and a dual Masters of Science degree and MBA in Global Healthcare Management from The Heller School at Brandeis University in Mass. Chris currently lives in Plattsburgh, N.Y. Leah Hennessey was recently hired as marketing manager. Leah is a designer and leukemia survivor with a passion for storytelling and making positive impacts on the lives of patients and survivors. After her diagnosis, she started a fundraising campaign called The Positive Project, for Roswell Park Cancer Center, where she received her treatment, including a bone marrow transplant, by selling handmade illustrative cards with uplifting messages inspired by fellow patient’s stories. Leah has been working with startups since 2015 and loves high-growth, high-energy environments. In her spare time, Leah enjoys running, biking, drawing, reading, and playing with her dogs. Leah grew up in Chatham, N.Y., received a Bachelors of Arts degree from the University at Buffalo and currently lives in Baldwinsville, N.Y. Liz Hiles was recently hired as an engagement specialist. Diagnosed with Stage III-B, non-metastatic bladder cancer with a T4 tumor in August 2016, she had her bladder removed with a stoma/urostomy placed, followed by chemotherapy. Liz has worked with several non-profit organizations as well in the education field. After healing from her experience with cancer, she transitioned to writing and advocacy work full-time. She is passionate about advocating for young adults in the cancer, bladder cancer and ostomy communities, serving as a community manager and contributing writer for select groups. Liz hails from Cincinnati and received her Bachelors of Arts degree in Sociology from Ohio University in Athens, as well as certifications in Women’s Studies and Cross-Cultural Competencies. Dr. Daniel Platt joined GRYT Health in 2020 as vice president of research and patient engagement and was recently promoted to chief medical officer. He has spent the majority of his life engaged in making the healthcare system more responsive to the needs of patients. Dan holds a Doctor of Medicine (M.D.) degree with distinction in research from the University of Rochester School of Medicine and Dentistry. He recently moved back to Rochester after having spent the last 10 years in Boston as a resident in neurology and consultant to biotech, pharma, and industry. Dan has extensive experience in the immuno-oncology space, having also served as the executive director, medical strategy and development, for Advaxis Immunotherapies. He is passionate about improving the prevention and treatment of cancer, educating and advocating for patients, and reshaping healthcare to be effective, efficient, and equitable. Uma Rana recently joined the organization as senior vice president of empowerment. Uma was the lead project manager for Bristol Myers Squibb Patient Advocacy and has led many key strategic initiatives across the organization. Her extensive experience in program/project management, strategy, operations, resource planning, financial, procurement, and relationship management will enhance GRYT Health’s core capabilities and help drive project success. Uma holds a Bachelors of Science degree in Pre-Med/Biology with Honors from Rider University and a MBA from New York Institute of Technology. She currently lives in East Windsor, N.J. Eileen Shannon was recently hired as vice president of client relations. In this role, she works closely with GRYT Health champions within client organizations to learn what makes them most proud of their work, and to help align resources to deliver those results. Eileen brings over 14 years of experience in non-profit fundraising and alumni relations. As a supporter of both family and friends who have experienced cancer, Eileen finds profound personal meaning in GRYT Health’s mission. Eileen holds a Bachelors of Science degree in Professional & Technical Communication and a Masters of Science degree in Communication & Media Technologies, both from Rochester Institute of Technology. She resides in Rochester, N.Y. Sam Schneider was recently hired as a senior research coordinator. Sam joins GRYT Health from Seattle Children's Hospital and Research Institute where he spent three years as a research scientist in CAR T-cell (cancer) research, drug development, and clinical trials. He earned his Bachelors of Science degree in Chemistry from Western Washington University. Sam grew up in Bainbridge Island, Wash. and now lives in Hilo, HI. Benjamin Valence joined the organization in 2019 as a front-end developer and was recently promoted to the role of manager of front-end development. In this role, he oversees a team of professionals to develop, build and host virtual patient education offerings for GRYT Health’s industry and advocacy clients. Ben has an eye for detail, and deeply cares about providing an exceptional user experience. He understands the emotions and need for information that go along with cancer, having been a caregiver for his sister during her treatment for colon cancer. Skilled at working with his hands, Ben has enjoyed experiences as a craftsman and barber. He has also served as a youth pastor for local churches in Rochester, N.Y. Ben grew up in and currently lives in Henrietta, N.Y. Jessica Valence was recently promoted to the role of vice president, education and empowerment. In this role, she helps to create virtual spaces for patient-focused companies to connect with their audiences in a new and authentic way. Jessica has been with GRYT Health since 2017 and has held a number of roles in assisting the company to evolve, including positions in Marketing and Operations. As a colon cancer survivor, Jessica holds a unique passion for helping to elevate the patient's voice and providing organizations a better understanding of the needs within their own communities. Prior to GRYT Health, she worked with a number of Rochester-based start-ups to amplify awareness and increase efficiencies. Growing up in Rochester, N.Y., Jessica attended Monroe Community College and earned her Bachelors of Arts degree in Art Education from Roberts Wesleyan College. She currently lives in Rochester, N.Y. GRYT Health is a digital oncology company that empowers people to be in charge of their own health through education, engagement and support. We offer a community free from judgment that focuses on humanity and the value each person brings. Our mission is to improve quality of life and increase survival for people facing cancer through the relentless focus on patient experience. We put patients first and work with healthcare organizations that do the same. We use the patient voice to enhance drug development and access; and together, we are helping to move healthcare forward. Visit www.grythealth.com to learn more. Contact Details Nichole Owens +1 315-263-4618 nichole@grythealth.com Company Website https://www.grythealth.com

August 24, 2021 02:09 PM Eastern Daylight Time

Image
Article thumbnail News Release

New CBD-Infused Hair and Skin Care Line Launching at Cosmoprof

LuckCBD

LUCKCBD announced today the official launch of its line of “Good Mojo” CBD hair and skin care products. These high-performing products include USA-grown CBD isolate along with other high-quality and effective ingredients. LUCK CBD is committed to offering products specially formulated with CBD to help people achieve their goal of beautiful, healthy hair and skin. LUCK CBD will debut its product line at the upcoming Cosmoprof North America (CPNA) exhibition in Las Vegas, Nev. on Aug. 29-31, 2021, at booth number 45192. LUCK CBD has been selected as one of the few brands to be featured in Cosmo Trends, the annual beauty report that advises the beauty industry of the most innovative products at Cosmo Prof. “We’re very excited to bring Good Mojo to the beauty space with our line of CBD-infused products. Not only does CBD represent one of the fastest-developing sectors in the country, but I’ve felt the market was missing something particularly in hair care. We use a healthy-hair matrix that includes organic pea shoot extract, amino acids, and USA-farmed CBD. We believe this combination results in outstanding formulas that work,” says Annie Seal, President, and Owner of LUCK CBD. “Our products use these efficacious, high-quality ingredients and we’re seeing that LUCK CBD products truly help people reach their personal hair goals.” The product line includes shampoo, conditioner, hair serum, hair mask, and all-over skin oil. The color-safe shampoo and conditioner are available in two scents, rosemary lavender, and peppermint essential oils to provide an aromatherapy experience. Each LUCK CBD product contains CBD oil that is Botanacor or Pro Verde certified to ensure consumers are receiving the highest quality CBD, without the THC and within federal regulations. LUCK CBD products are packed with ingredients that can help restore hair. We believe the CBD helps ingredients work efficiently. The super gentle sudsing agents helps hair to rinse clean, so there is no residue, film, or oil left on the hair. The result is clean, nourished hair, so that ones’ natural beauty can shine through. LUCK CBD products contain a variety of high-quality ingredients, including: Organic pea shoot extract, which has been shown to help with hair regrowth Amino acids, which are known for their contributions to hair structure and strength Argan, which is known to be a non-clogging superfood for the skin that can help boost the skin naturally Jojoba, which has antibacterial properties and antioxidants, which has been shown to soothe and nourish irritated skin MCT, which is a concentrated form of coconut oil that’s high in fat and can help condition and tone skin CBD isolate, which has been shown to have a myriad of health benefits LUCK CBD believes in the magic of CBD as one of nature's miracles. LUCK CBD is focused on creating products based on this Good Mojo philosophy. When consumers have Good Mojo, they feel joyful, more amazing, and hopefully more motivated to pay happiness forward. LUCK CBD’s goal is to bring these revolutionary beauty products into households across the country to help consumers satisfy their personal hair and skin goals. “Each product is made specifically to help consumers get what they desire for their own hair and skin, whether it is volume, hair growth, shine, better texture and more,” says Seal. “We are excited to launch at Cosmoprof so that we can introduce LUCK CBD products to the entire beauty community.” LUCK CBD products are available online at www.luckcbd.com and select local salons in the St. Louis, Mo. area. About LUCKCBD and The Luck Company, LLC LUCKCBD, and The Luck Company, LLC, is a certified women-owned business that offers beauty and wellness products based on the magic of CBD. Founded in 2020 in St. Louis, Missouri, the company has formulated a myriad of products formulated to assist with healthy living goals. Visit www.luckcbd.com for more information. Contact Details Jeremy Rives jrives@sedlockpartners.com Company Website https://www.luckcbd.com

August 24, 2021 09:03 AM Eastern Daylight Time

Image
Article thumbnail News Release

Centre for Neuro Skills Signs Agreement With Political Subdivision Workers’ Compensation Alliance Covering More Than 500,000 Texas Public Entities’ Employees

Centre for Neuro Skills

The Texas Brain Injury Alliance reports that 144,000 Texans sustain a traumatic brain injury each year - one every 4 minutes. Centre for Neuro Skills (CNS), a premier provider of treatment for traumatic and acquired brain injury, announced today it is now a participating provider in the Political Subdivision Worker’s Compensation Alliance’s (PSWCA) direct contracting program. Five risk pools that offer workers’ compensation coverage and claims services to public entities in Texas, representing more than 3,000 public employers and 500,000 employees, formed PSWCA in 2006. The types of public entity employers include schools, community colleges, cities, counties, community centers, water districts and other local public authorities. “Our focus is identifying and contracting with the best quality and most efficient health care providers,” said Phil Hambrick, PSWCA’s director of provider network development. “Our goal with our participating providers, such as the Centre for Neuro Skills, is that rehabilitation therapies lead to better outcomes for injured employees.” CNS has four locations in Texas. It recently opened its newest clinic in Austin. Other Texas CNS facilities are in Dallas, Fort Worth and Houston. All CNS clinics offer a continuum of care approach to therapeutic rehabilitation and disease management services for those recovering from traumatic and acquired brain injuries. “What sets CNS apart is our whole team approach on patients and their caregivers,” said Paul Greenspan, AVP payor strategy at CNS. “Our entire team in Texas looks forward to working with PSWCA and providing essential rehabilitation therapies to Texas’ public entity employees who need them. We strive to ensure the best possible recovery with the goal of helping injured workers maximize their independence and improve their quality of life. Our return-to-work rates are outstanding with 56 percent of CNS patients returning to work.” About Centre for Neuro Skills Centre for Neuro Skills is an experienced and respected world leader in providing intensive rehabilitation and medical programs for those recovering from all types of brain injury. CNS covers a full spectrum of advanced care from residential and assisted living to outpatient/day treatment. Founded by Dr. Mark Ashley in 1980, CNS has seven locations in California and Texas. For more information about Centre for Neuro Skills, visit: www.neuroskills.com, Facebook, Twitter, LinkedIn, YouTube. Media, please note: Visual assets, including photos, are available. To request an interview with CNS leadership, please call ontact Sean Dowdall at (415) 286-7121 or CNS@landispr.com. # # # Contact Details Sean Dowdall +1 415-286-7121 CNS@landispr.com Company Website https://www.neuroskills.com/

August 24, 2021 06:20 AM Eastern Daylight Time

Image
Article thumbnail News Release

Healthtech wearable glucose tracker Ultrahuman raises $17.5m in series B funding

Ultrahuman

Ultrahuman, the rapidly growing metabolic fitness platform, today announced it has raised $17.5 million, as it aims to help over a billion people in the world suffering from a metabolic health disorder. This brings the total funds raised so far to $25mn. Ultrahuman is committed to making metabolic fitness accessible to millions of people globally. The funds raised will be used for geographical expansion and to improve their biomarker technology. The series B funding came from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund. Marquee founders and angel investors also participated including Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini. The Ultrahuman Cyborg wearable helps people optimize their exercise and nutrition based on glucose biomarkers. The Ultrahuman wearable launched in June 2021 has already amassed thousands of users in the waitlist with users raving about their experience on Twitter after using the wearable. The metabolic health crisis is unarguably one of the largest healthcare crises that exists today. Over a billion people in the world suffer from a metabolic health disorder which contribute to almost 85% of all chronic diseases in the world. By helping people understand how food and exercise affects their metabolic health, people would be able to make informed choices about what they eat and their activity levels. The approach is a geography / diet agnostic way to help people eat and exercise better. A single biomarker like glucose can reveal so much about how a particular food item affects the user’s metabolic health by measuring the glucose response. This response is unique to an individual and it depends on various factors like their microbiome diversity, stress levels, time of the day, food ingredient quality etc. Ultrahuman was started by Mohit Kumar and Vatsal Singhal who were also co-founders at Runnr that later merged with Zomato. Mohit is an avid cyclist, biohacker and Brazilian Jiu-Jitsu enthusiast. Vatsal is a cross fit enthusiast and biohacker. Mohit was training at one of the largest MMA Camps in the world (Tiger Muay Thai). There he observed athletes train smartly via usage of data, recovery tools and protocols. He got together with Vatsal and they came up with a vision for Ultrahuman where they can make the journey of fitness for people more personalised and impactful. “Biomarkers will change how the fitness and the healthcare industry works. By being able to continuously monitor their biomarkers like glucose, users can not only avoid chronic diseases but make lifestyle changes that help them improve their fitness levels for longevity and performance, ” said Ultrahuman Founder and CEO Mohit Kumar. Navroz D. Udwadia, Co-Founder, Falcon Edge Capital, said, " We are excited to partner with Mohit and Vatsal, founders of Ultrahuman. We believe they can transform the way people view personal wellness globally. Their thoughtfulness around UI / design and consumer experience is inspiring. We are thrilled to back what could be a pioneering biomarker-driven global healthcare business. Their dual obsessiveness around product engineering and customer experience is already showing result in terms of product market fit and retention. ” Commenting on the investment, Ravi Mehta, Founder and MD Steadview Capital, said, “ We are excited to be a part of Ultrahuman’s journey as it takes what we believe to be a disruptive approach to personal wellness. Ultrahuman’s biosensor-enabled, data-first model, in our view, is the future of any personalized healthcare ecosystem, ” “We at Nexus are super excited about Ultrahuman’s biomarker based approach to build hyper- personalised diet and exercise journeys for users. We are seeing a very strong pull for Ultrahuman’s Cyborg platform globally and feel that it will be a foundational approach to personal wellness in the years to come, ” added Sameer Brij Verma, MD Nexus Venture Partners. “Mohit and team have taken their personal fitness journeys and translated them to a world class product and experience in just over a year. We expect Ultrahuman to help shape how health is proactively monitored across global audiences, “ said Karthik Reddy, Founder of Blume Ventures. About Ultrahuman Ultrahuman is headquartered in the US and India. It is the world's most advanced metabolic fitness platform. It helps people create long-term habits and changes via instant nudges and deep health insights instead of diets and strict exercise routines. For more information and updates on Ultrahuman, please visit ultrahuman.com Contact Details Ultrahuman Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com

August 19, 2021 08:00 AM Pacific Daylight Time

Image
1 ... 159160161162163 ... 194